5-Endo-dig electrophilic cyclization of α-alkynyl carbonyl compounds: Synthesis of novel bicyclic 5-iodo- and 5-bromofuranopyrimidine nucleosides

Journal of Organic Chemistry

Volumn 68, Issue 17, 2003, Pages 6788-6790

  Srinivasa Rao, Meneni ^a   Esho, Noor ^a   Sergeant, Craig ^a   Dembinski, Roman ^a  

^a OAKLAND UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELECTROPHILIC CYCLIZATION;

ACETONE; PRECIPITATION (CHEMICAL); SYNTHESIS (CHEMICAL);

NITROGEN COMPOUNDS;

3 (2' DEOXY BETA DEXTRO RIBOFURANOSYL) 5 BROMO 2,3 DIHYDROFURO[2,3 D]PYRIMIDIN 2 ONE; 3 (2' DEOXY BETA DEXTRO RIBOFURANOSYL) 5 IODO 2,3 DIHYDROFURO[2,3 D]PYRIMIDIN 2 ONE; 5 BROMOFURANOPYRIMIDINE; 5 IODOFURANOPYRIMIDINE; ACETONE; CARBONYL DERIVATIVE; DEOXYURIDINE; N BROMOSUCCINIMIDE; N IODOSUCCINIMIDE; NUCLEOSIDE DERIVATIVE; PALLADIUM; PYRIMIDINE DERIVATIVE; SUCCINIMIDE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CATALYST; CYCLIZATION; DRUG SYNTHESIS; FLUORESCENCE; MASS SPECTROMETRY; PROTON NUCLEAR MAGNETIC RESONANCE; ROOM TEMPERATURE;

BICYCLO COMPOUNDS; BROMINE; INDICATORS AND REAGENTS; MOLECULAR CONFORMATION; PYRIMIDINE NUCLEOSIDES;

EID: 0042009107     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo0345648     Document Type: Article

References (61)

1. (a) König, B. Furan. In Hetarenes and Related Ring Systems; Science of Synthesis; Maas, G., Ed.; George Thieme Verlag: Stuttgart, 2001; Category 2, Vol. 9, pp 183-285.
2. (b) Dell, C. P. Benzo[b]furans. In Hetarenes and Related Ring Systems; Science of Synthesis; Thomas, E. J., Ed.; George Thieme Verlag: Stuttgart, 2000; Category 2, Vol. 10, pp 11-86.
3. (c) Eberbach, W. Furan. In Houben-Weyl; George Thieme Verlag: Stuttgart, 1994; E6a, Teil I, pp 16-185d.
4. (d) Hou, X. L.; Cheung, H. Y.; Hon, T. Y.; Kwan, P. L.; Lo, T. H.; Tong, S. Y.; Wong, H. N. C. Tetrahedron 1998, 54, 1955-2020.
5. Mendez-Andino, J.; Paquette, L. A. Org. Lett. 2000, 2, 4095-4097 and references therein.
6. Horton, D. A.; Bourne, G. T.; Smythe, M. L. Chem. Rev. 2003, 103, 893-930.
7. (a) Gilchrist, T. L. J. Perkin 1 2001, 2491-2515.
8. (b) Gilchrist, T. L. J. Chem. Soc., Perkin Trans. 1 1999, 2849-2866.
9. (a) Larock, R. C. Palladium-Catalyzed Annulation. In Perspectives in Organopalladium Chemistry for the XXI Century; Tsuji, J., Ed.; Elsevier Press: Lausanne, Switzerland, 1999; pp 111-124.
10. (b) Larock, R. C. Pure Appl. Chem. 1999, 71, 1435-1442.
11. (c) Larock, R. C. J. Organomet. Chem. 1999, 576, 111-124.
12. (d) Larock, R. C.; Yum, E. K.; Doty, M. J.; Sham, K. K. C. J. Org. Chem. 1995, 60, 3270-3271.
13. Kel'in, A. V.; Gevorgyan, V. J. Org. Chem. 2002, 67, 95-98.
14. Arcadi, A.; Cacchi, S.; Fabrizi, G.; Marinelli, F.; Moro, L. Synlett 1999, 1432-1434.
15. Arcadi, A.; Cacchi, S.; Di Giuseppe, S.; Fabrizi, G.; Marinelli, F. Org. Lett. 2002, 4, 2409-2412.
16. (a) El-Taeb, G. M. M.; Evans, A. B.; Jones, S.; Knight, D. W. Tetrahedron Lett. 2001, 42, 5945-5948.
17. (b) Bew, S. P.; Barks, J. M.; Knight, D. W.; Middleton, R. J. Tetrahedron Lett. 2000, 41, 4447-4451.
18. (c) Bew, S. P.; Knight, D. W. Chem. Commun. 1996, 1007-1008.
19. (d) Nichols, C. J.; Parks, J. J. J. Undergrad. Chem. Res. 2002, 1, 27-32.
20. (e) See also: Knight, D. W.; Redfern, A. L.; Gilmore, J. J. Perkin 1 2002, 622-628.
21. 2) leads also to iodofuran derivatives: Buckle, D. R.; Rockell, C. J. M. J. Chem. Soc., Perkin Trans. 1 1985, 2443-2446.
22. Ren, X.-F.; Turos, E. Tetrahedron Lett. 1993, 34, 1575-1578.
23. (a) Yue, D.; Larock, R. C. J. Org. Chem. 2002, 67, 1905-1909.
24. (b) Larock, R. C.; Yue, D. Tetrahedron Lett. 2001, 42, 6011-6013.
25. Lee, C.-F.; Yang, L.-M.; Hwu, T.-Y.; Feng, A.-S.; Tseng, J.-C.; Luh, T.-Y. J. Am. Chem. Soc. 2000, 122, 4992-4993.
26. (a) Robins, M. J.; Vinayak, R. S.; Wood, S. G. Tetrahedron Lett. 1990, 31, 3731-3734.
27. (b) Cruickshank, K. A.; Stockwell, D. L. Tetrahedron Lett. 1988, 29, 5221-5224.
28. (c) Robins, M. J.; Barr, P. J. J. Org. Chem. 1983, 48, 1854-1862.
29. (d) Robins, M. J.; Barr, P. J. Tetrahedron Lett. 1981, 22, 421-424.
30. (e) Crisp, G. T.; Flynn, B. L. J. Org. Chem. 1993, 58, 6614-6619.
31. Review: Korshun, V. A.; Manasova, E. V.; Berlin, Yu. A. Bioorganicheskaya Khimia 1997, 23, 324-387 (in Russian).
32. Yu, C. J.; Yowanto, H.; Wan, Y.; Meade, T. J.; Chong, Y.; Strong, M.; Donilon, L. H.; Kayyem, J. F.; Gozin, M.; Blackburn, G. F. J. Am. Chem. Soc. 2000, 122, 6767-6768.
33. Reviews: (a) De Clercq, E. D. Med. Res. Rev. 2003, 23, 253-274.
34. (b) Balzarini, J.; McGuigan, C. Biochim. Biophys. Acta 2002, 1587, 287-295.
35. (c) Balzarini, J.; McGuigan, C. J. Antimicrob. Chemother. 2002, 50, 5-9.
36. (d) McGuigan, C.; Brancale, A.; Barucki, H.; Srinivasan, S.; Jones, G.; Pathirana, R.; Carangio, A.; Blewett, S.; Luoni, G.; Bidet, O.; Jukes, A.; Jarvis, C.; Andrei, G.; Snoeck, R.; De Clercq. E.; Balzarini, J. Antiviral Chem. Chemother. 2001, 12, 77-89.
37. (e) McGuigan, C.; Brancale, A.; Barucki, H.; Srinivasan, S.; Jones, G.; Pathirana, R.; Blewett, S.; Alvarez, R.; Yarnold, C. J.; Carangio, A.; Velázquez, S.; Andrei, G.; Snoeck, R.; De Clercq, E.; Balzarini, J. Drugs Future 2000, 25, 1151-1161.
38. (a) McGuigan, C.; Barucki, H.; Blewett, S.; Carangio, A.; Erichsen, J. T.; Andrei, G.; Snoeck, R.; De Clercq, E.; Balzarini, J. J. Med. Chem. 2000, 43, 4993-4997.
39. (b) Brancale, A.; McGuigan, C.; Andrei, G.; Snoeck, R.; De Clercq, E.; Balzarini, J. Bioorg. Med. Chem. Lett. 2000, 10, 1215-1217.
40. (c) McGuigan, C.; Yarnold, C. J.; Jones, G.; Velázquez, S.; Barucki, H.; Brancale, A.; Andrei, G.; Snoeck, R.; De Clercq, E.; Balzarini, J. J. Med. Chem. 1999, 42, 4479-4484.
41. Conversion of alkynyl uridines to 5-aryl substituted furano pyrimidines has been reported: Carangio, A.; McGuigan, C.; Andrei, G.; Snoeck, R.; De Clercq, E.; Balzarini, J. Antiviral Chem. Chemother. 2001, 12, 187-197. Also carbonylative annulation allows for functionalization of benzofurans at analogous position: Liao, Y.; Reitman, M.; Zhang, Y.; Fathi, R.; Yang, Z. Org. Lett. 2002, 4, 2607-2609. Chaplin, J. H.; Flynn, B. L. Chem. Commun. 2001, 1594-1595.
42. Conversion of alkynyl uridines to 5-aryl substituted furano pyrimidines has been reported: Carangio, A.; McGuigan, C.; Andrei, G.; Snoeck, R.; De Clercq, E.; Balzarini, J. Antiviral Chem. Chemother. 2001, 12, 187-197. Also carbonylative annulation allows for functionalization of benzofurans at analogous position: Liao, Y.; Reitman, M.; Zhang, Y.; Fathi, R.; Yang, Z. Org. Lett. 2002, 4, 2607-2609. Chaplin, J. H.; Flynn, B. L. Chem. Commun. 2001, 1594-1595.
43. Conversion of alkynyl uridines to 5-aryl substituted furano pyrimidines has been reported: Carangio, A.; McGuigan, C.; Andrei, G.; Snoeck, R.; De Clercq, E.; Balzarini, J. Antiviral Chem. Chemother. 2001, 12, 187-197. Also carbonylative annulation allows for functionalization of benzofurans at analogous position: Liao, Y.; Reitman, M.; Zhang, Y.; Fathi, R.; Yang, Z. Org. Lett. 2002, 4, 2607-2609. Chaplin, J. H.; Flynn, B. L. Chem. Commun. 2001, 1594-1595.
44. In a preliminary studies, the iodonucleoside 3a was tested using cytotoxicity assay and exhibited activity comparable to 5-fluorouracil. We are indebt to Prof. Rasul Chaudry for this experiment.
45. 4C≡CH in Sonogashira conditions. We thank Ms. Bo Bezeau for this observation.
46. Synthesis of 6-bromofurano pyrimidine (2, R = Br): Eger, K.; Jalalian, M.; Schmidt, M. J. Heterocycl. Chem. 1995, 32, 211-218.
47. (a) De Clercq, E. Antiviral activity of nucleoside analogues: the BVDU connection. In Recent Advances in Nucleosides: Chemistry and Chemotherapy; Chu, C. K., Ed.; Elsevier Science: New York, 2002; pp 433-454.
48. (b) Walker, R. T.; De Clercq, E. Pharmacol. Ther. 1984, 26, 1-44.
49. (c) De Clercq, E.; Descamps, J.; De Sommer, P.; Barr, P. J.; Jones, A. S.; Walker, R. T. Proc. Natl. Acad. Sci. U.S.A. 1979, 76, 2947-2951.
50. (d) See also: Guenther, S.; Balzarini, J.; De Clercq, E.; Nair, V. J. Med. Chem. 2002, 45, 5426-5429.
51. (a) Zemlicka, J. Unusual analogues of nucleosides: chemistry and biological activity. In Recent Advances in Nucleosides: Chemistry and Chemotherapy; Chu, C. K., Ed.; Elsevier Science: New York, 2002; pp 327-357.
52. (b) De Clercq E. Biochim. Biophys. Acta 2002, 1587, 258-275.
53. (c) Pietruszka, J. Chem. Rev. 2003, 103, 1051-1070.
54. For application of NBS in relevant nucleoside chemistry see: Kumar, R.; Nath, M.; Tyrrell, D. L. J. J. Med. Chem. 2002, 45, 2032-2040.
55. For NBS bromination of furan ring, see: (a) Grubenmann, W.; Erlenmeyer, H. Helv. Chim. Acta 1948, 31, 78-83. (b) Lukevics, E.; Ignatovich, L.; Goldberg, Yu.; Polyak, F.; Gaukhman, A.; Rozite, S.; Popelis, J. J. Organomet. Chem. 1988, 348, 11-23.
56. For NBS bromination of furan ring, see: (a) Grubenmann, W.; Erlenmeyer, H. Helv. Chim. Acta 1948, 31, 78-83. (b) Lukevics, E.; Ignatovich, L.; Goldberg, Yu.; Polyak, F.; Gaukhman, A.; Rozite, S.; Popelis, J. J. Organomet. Chem. 1988, 348, 11-23.
57. (a) Sonogashira, K. Cross-coupling Reactions to sp Carbon Atoms. In Metal catalyzed Cross-coupling Reactions; Diederich, F., Stang, P. J., Eds.; Wiley-VCH: Weinheim, 1998; pp 203-230.
58. (b) Nakamura, K.; Okubo, H.; Yamaguchi, M. Synlett 1999, 549-550.
59. Esho, N.; Davies, B.; Lee, J.; Dembinski, R. Chem. Commun. 2002, 332-333.
60. Kobayashi, Y.; Nakano, M.; Kumar, G. B.; Kishihara, K. J. Org. Chem. 1998, 63, 7505-7515.
61. See, for example: Okamoto, A.; Tainaka, K.; Saito, I. J. Am. Chem. Soc. 2003, 125, 4972-4973.